28th National Clinical Education Symposium Presentation Abstracts

20 APRIL 2026, MONDAY
10:15 - 11:30 OP-12 Efficacy of rTMS Treatment in Treatment-Resistant Major Depressive Disorder: The Role of Sociodemographic Characteristics and Duration of Illness on Treatment Response

OP-12 Efficacy of rTMS Treatment in Treatment-Resistant Major Depressive Disorder: The Role of Sociodemographic Characteristics and Duration of Illness on Treatment Response

Erşad Yasin Yıldız1, Pelin Goksel1, Gökçe Çamoğlu1

1. Department of Psychiatry, Ondokuz Mayıs University, Samsun, Turkey


DOI: 10.5080/61upk.ozt431 Page 75

BACKGROUND AND AIM Major Depressive Disorder (MDD) is a chronic condition where full remission remains elusive for a significant portion of patients despite standard interventions. The objective of this study was to examine the efficacy of high-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (DLPFC) on depressive symptoms in patients with treatment-resistant MDD, and to evaluate the impact of factors such as age, gender, and duration of illness on treatment response.
METHODS Approved by the Ondokuz Mayıs University Clinical Research Ethics Committee (Decision No: 2026/29), this retrospective study included 24 patients (18 female, 5 male; mean age: 47.65 ± 11.29 years) diagnosed with treatment-resistant MDD. Patients underwent 20 rTMS sessions (5 days/week for 4 weeks). Treatment efficacy was analyzed by comparing Hamilton Depression Rating Scale (HAM-D) scores assessed immediately before the first and after the final session. All patients received concurrent psychopharmacological treatment. However, due to the retrospective design and heterogeneity/missing data regarding medication usage, between-group comparisons based on dose equivalence were not performed.
RESULTS The mean pre-treatment HAM-D score was 15.62 ± 5.59, which significantly decreased to 7.75 ± 6.39 following rTMS treatment (p<0.001), representing a mean improvement of 7.87 points. No statistically significant relationship was found between treatment response and age (p=0.41), duration of illness (p=0.08), gender (p=0.87), or marital status (p=0.37).
CONCLUSIONS Our results confirm that high-frequency rTMS applied to the left DLPFC is highly effective in reducing symptom severity in treatment-resistant depression. Crucially, treatment response was not influenced by age, gender, or illness duration. This suggests that rTMS remains a robust therapeutic option even for chronic, longstanding cases, supporting its use across a diverse patient demographic Keywords: Major depressive disorder, Treatment-resistant depression, Repetitive transcranial magnetic stimulation (rTMS), Sociodemographic factors, Duration of illness, Treatment efficacy